Optimal Treatment Approaches to Intestinal Beh çet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
CONCLUSION: Patients with intestinal BD-MDS frequently have refractory diseases with high mortalities. HSCT can be an effective treatment modality for medically refractory patients with intestinal BD-MDS.PMID:38653565 | DOI:10.3349/ymj.2023.0321
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Jung-Bin Park So Jung Han Seung Bum Lee Dong Hyun Kim Jae Hee Cheon Sung Wook Hwang Byong Duk Ye Suk-Kyun Yang Soo Jung Park Sang Hyoung Park IBD Research Group of the Korean Association for the Study of Intestinal Diseases and the Korean Society for Behc Source Type: research
More News: Myelodysplastic Syndrome | Stem Cell Therapy | Stem Cells | Study | Transplants | Universities & Medical Training